28 Jun 2026
Top Defensive Income Plays on the ASX: TLS, TCL and WOW
We've had a rough week on the ASX, and honestly, it's hard to see what breaks the pressure in the near term. The index has been grinding lower across most sessions, with selling br

We've had a rough week on the ASX, and honestly, it's hard to see what breaks the pressure in the near term. The index has been grinding lower across most sessions, with selling br
Hi Eason,
*Top Defensive Income Plays on the ASX: TLS, TCL and WOW*
We've had a rough week on the ASX, and honestly, it's hard to see what breaks the pressure in the near term. The index has been grinding lower across most sessions, with selling broad enough to hit materials, energy, financials, and gold miners all at once, the kind of market where there aren't many places to hide. What we're dealing with is a confluence of macro forces that don't resolve quickly, and we think investors need to understand each piece before deciding how to position. It starts with the Fed. New Federal Reserve Chair Kevin Warsh used his first FOMC meeting on June 17 to deliver a hawkish surprise, leaving rates unchanged at 3.50%-3.75%, but stripping out the earlier easing tilt and nudging the dot-plot median year-end 2026 projection up to around 3.8%. That's essentially the Fed indicating that at least one more hike is baked into their thinking. And markets heard it loud and clear. According to CME FedWatch, futures traders are now pricing just a 72.2% chance of a hold in July, meaning there's a live 27.8% probability of a 25-basis-point hike as soon as next month. By September, a hike is more than fully priced in, with 47.3% odds of a 25bp increase and a further 12.2% chance of 50bp of cumulative tightening. That hawkish repricing has sent the Bloomberg Dollar Spot Index up around 2% in June alone to its highest since November 2025. Here's why that matters for us: a stronger US dollar is a reliable headwind for commodity prices, and commodity prices drive a big chunk of the ASX. Materials fell for a sixth consecutive session this week. That's the transmission mechanism, and it's working exactly as you'd expect.
*The RBA's Own Tightening Cycle Is Keeping a Lid on the Local Economy*
The rate pressure isn't just coming from offshore, we've got our own version of this playing out at home. The RBA has delivered three consecutive 25-basis-point hikes in 2026, bringing the cash rate to 4.35%, back to the cycle peak from 2024. At the June meeting, the Board chose to pause and assess, which is the right call, but the language was far from dovish. Deputy Governor Andrew Hauser was explicit: inflation remains too high, and more work may still be needed. We're not out of the woods yet. The numbers back that up. The RBA's May Statement on Monetary Policy forecast headline CPI peaking at 4.8% in the June quarter 2026. May's monthly CPI print came in at 4.0% year-on-year, slightly softer than April's 4.2%, which gave markets a moment of relief, but core inflation re-accelerated to 3.6%, which is the number the RBA actually cares about. Then May's employment data landed stronger than expected, which was the final piece that reduced any near-term case for easing. After April's jobless rate spiked to 4.5%, its highest since late 2021, the market was hoping for confirmation of a softening economy. It didn't come. So, here's where we land: the big four banks are now split. CBA and NAB believe the RBA is effectively on hold for the rest of 2026. Westpac is more hawkish, still forecasting two more hikes in August and September.
*We think the most likely path is a prolonged hold, but the August 11 meeting is live, and the June quarter CPI data landing before then will be the key input. With economic growth revised down to just 1.3% for 2026 and household spending still squeezed by cost-of-living pressures, what we're watching for is a stagflationary dynamic taking hold. That's not a great backdrop for the broader index.*
*Enjoy my Research and Stock Picks?* Follow me on LinkedIn for more updates
( https://linkedin.com/in/markelzayed )
*Gold Breaks Below US$4,000, Near-Term Pain, But the Long Case Isn't Dead*
Gold is the story we want to be careful about right now. Spot gold settled at in the US$3,990 – US$4,022 range, recently breaking below the psychologically important US$4,000 level and hitting its lowest close since November 2025. That's a notable decline from the January all-time high of US$5,589, and locally it's been painful: Evolution Mining fell 3.9% and Northern Star shed 3.1% in Thursday's session alone. Here's how we think about the gold sell-off: it's not mysterious. Gold pays no yield. When US rate expectations rise and real yields tick higher, the opportunity cost of holding bullion goes up. And right now, the Fed is keeping rates higher for longer, Goldman Sachs has pushed its first expected Fed cut all the way out to 2027. Layered on top is the inflation dynamic. US CPI came in at 4.2% in May, but here's the nuance: more than 60% of that monthly increase was driven by energy, thanks to the Iran conflict. Energy-led inflation isn't cleanly bullish for gold, it keeps the Fed hawkish without undermining dollar confidence the way broad monetary debasement would.
*Technically, the picture is bearish.* Gold has closed below its 200-day moving average for the first time since October 2023. RSI is sitting at around 38 - 40 level, MACD is in negative territory, and there's no clear catalyst to reverse that momentum until we get the June CPI print on July 14 or a softening signal from the July 28-29 FOMC. So, we're cautious on gold near-term, we're not chasing bounces here. That said, we're not walking away from the long-term thesis. Central banks bought 244 tonnes net in Q1 2026, up 17% quarter-on-quarter. China has added to reserves for 18 consecutive months. Goldman still targets US$4,900 by year-end, JPMorgan sees US$5,000 in Q4, and 89% of reserve managers surveyed by the World Gold Council expect global central bank gold holdings to increase over the next 12 months. The structural case, de-dollarisation, reserve diversification, the debasement trade, is intact. This correction is tactical, not structural. But for the moment, rallies in gold are likely to be sold, and we'd rather wait for the macro picture to clear before adding exposure.
*Where Does That Leave Us?*
We've got a hawkish Fed, an RBA on pause but far from cutting, a stronger US dollar compressing commodity prices, a gold market in near-term freefall, and a local index that's lost its footing.
*In that environment, the playbook is clear:* we move toward quality defensive names with predictable cash flows, real pricing power, and low sensitivity to the rate cycle. We're not calling the all-clear on the broader ASX, we wouldn't do that with this much macro uncertainty still unresolved. But we are identifying five names that make sense to hold through this volatility. These are businesses that generate real earnings, pay reliable dividends, and genuinely don't need commodity prices or rate cuts to work.
*Wesfarmers Limited (ASX: WES), The Compounding Machine That Keeps Finding New Engines*
Wesfarmers is one of those businesses we come back to repeatedly, and the FY26 half-year results reminded us exactly why it commands a premium. For the six months ended 31 December 2025, revenue came in at $24.2 billion, up 3.1%, EBIT grew 8.4% to $2.49 billion, and statutory NPAT rose 9.3% to $1.60 billion. EPS of $1.41 beat consensus by 2.3%. Bunnings is still the crown jewel, now moving into automotive and smart home categories and ramping an online marketplace that's becoming increasingly meaningful. Kmart is chasing the fast-growing "kidult" category and launching K Home as a standalone brand. But what's really caught our attention in recent months is the longer-term optionality in lithium, the company is considering doubling production capacity at Mount Holland, and the health division, which is quietly building something interesting alongside Priceline.
On June 9, a quarterly update sent shares up 4.25% in a single session, significantly outperforming the broader index on a day when the market was broadly flat. That's the kind of price action that tells you institutional money is accumulating, not distributing. The return on equity is 39%, that's not an accident, it's the result of decades of disciplined capital allocation. EPS is forecast to grow 19% over the next three years, and the $1.02 interim dividend translates to a 4.3% yield, well above the industry average of 1.9%. Yes, at 28-29x trailing earnings WES isn't cheap. But with this quality of franchise and this earnings growth profile, we think that's a fair price to pay. From 1 July 2026, Blackwoods and Workwear Group fold into Bunnings, a move we think will surface cost savings and revenue synergies that aren't fully in the consensus numbers yet. The FY26 full-year result in August is the next catalyst to watch.
*Enjoy my Research and Stock Picks?* Follow me on LinkedIn for more updates
( https://linkedin.com/in/markelzayed )
*Woolworths Group (ASX: WOW), Supermarket Resilience in a Cost-of-Living Economy*
When Australian households are being squeezed by mortgage repayments, higher energy bills, and persistent inflation, they don't stop buying food. That's the simple thesis behind Woolworths, and the H1 FY26 results showed that the company is now executing well enough to benefit from it again. In the six months ended 4 January 2026, group EBIT grew strongly, driven by cost discipline, e-commerce expansion, and improved execution across food and everyday needs. Underlying profitability and margins improved across all segments, a clean result. Shares hit a 17-month high in the days after the February result, and the fully franked interim dividend of $0.45, 15% higher than the prior year, confirmed that management is confident enough in the cash flow outlook to return more to shareholders.
What we like about WOW's moat is its simplicity: 1,000+ stores, the Everyday Rewards loyalty program with millions of active members, and a growing online business that's capturing the convenience-seeking segment of the market. Jon Alferness, a former Walmart Chief Product Officer and Google executive, joined the board in March 2026, which tells us the company is serious about its digital and tech capability. Net income is forecast to grow 148% in FY26 as one-off payroll remediation costs roll off the base. And at the current price of around $38.74, with intrinsic value estimated around $62.70, we think there's a meaningful valuation gap that a re-rating could close. Over the past three months the stock has been building a clean series of higher lows, with the 50-day moving average providing support through the recent ASX weakness. Revenue growth of 3.8% per annum isn't exciting on paper, but in this environment, predictable and growing is exactly what we want.
*Enjoy my Research and Stock Picks?* Follow me on LinkedIn for more updates
( https://linkedin.com/in/markelzayed )
*Telstra Group (ASX: TLS), The Dividend Anchor in a High-Rate World*
We like Telstra here because it tends to do exactly what we need it to do when markets are noisy: hold its ground, pay its dividend, and let the recurring revenue do the heavy lifting. The H1 FY26 results released February 18 showed a 9.4% rise in half-year profit, with steady mobile contributions and ongoing cost-out from the T25 program. And if we go back to FY25, the numbers were genuinely impressive, EBITDA grew 14% and statutory profit rose 31%, which reflects the operating leverage that years of network investment is finally delivering. Telstra's moat is network scale, full stop. The company covers 99.6% of the Australian population and has 5G deployed to more than 85% of Australians. No competitor can replicate that without decades of capital, spectrum auctions, and infrastructure build-out. That scale translates directly into 22.5 million-plus retail mobile accounts, growing ARPU, and a recurring revenue base that is almost entirely insensitive to the economic cycle. People don't cancel their mobile plans when the RBA hikes rates.
TLS shares are currently sitting close to their 52-week high, a notable contrast to the rest of the ASX, which has been selling off aggressively. Relative strength has been consistently positive through the June weakness. The dividend is fully franked, which adds meaningful post-tax value for Australian retail investors. Telstra also sold its Versent Group stake to Infosys for $233 million in early 2026, which tells us management is disciplined about sweating non-core assets. FY26 guidance points to further cash EBIT growth and continued capital returns. The way we think about this one: we're getting paid a fully franked dividend to sit on one of Australia's most resilient cash-generating businesses while the macro picture resolves itself. The 200-day moving average is holding as strong support, and we'd use any dip toward that level as an opportunity to add.
*Transurban Group (ASX: TCL), Inflation-Linked Toll Roads You Can Set and Forget*
People often call Transurban a bond proxy, and we understand why, but we think that framing actually undersells what makes this company interesting right now. Unlike a bond, Transurban's revenue is directly indexed to CPI. Every toll on its 22-motorway portfolio across Melbourne, Sydney, Brisbane, and North America is contractually linked to inflation. So, in an environment where CPI is running at 4%, Transurban's revenue is growing at 4% in real terms before a single additional car gets on the road. That's a structural hedge that very few businesses can offer, and it's particularly valuable when the RBA is fighting inflation and household incomes are under pressure. The company recently confirmed its FY26 distribution payout and updated the market on annual meeting timing and has been actively working with the NSW government on a digital overhaul of unpaid toll collection, a reform that should meaningfully reduce revenue leakage on its Sydney assets. CityLink in Melbourne, the Hills M2 in Sydney, the Logan Motorway in Brisbane, and the 495 Express Lanes around Washington DC are all performing well, with traffic volumes tracking above pre-COVID levels on most corridors.
The current dividend yield of around 4.3% sits above the five-year historical average of 3.6%. We read that as the market still pricing in some residual rate risk, but with the RBA likely at or near peak rates, and with CPI-linkage protecting revenues regardless, we think that discount is overdone. TCL's price action has been notably resilient through the recent ASX weakness, holding above the 50-day moving average while materials and energy stocks were being sold aggressively. The $36 billions of infrastructure protecting Sydney's road network alone is near-impossible to replicate. If rate expectations begin to soften into 2027, which is what most major banks are now forecasting, TCL is well-positioned for a meaningful re-rating.
*CSL Limited (ASX: CSL), Healthcare's Compounding Giant Is Back*
CSL is the kind of business that we always want somewhere in our portfolio, it just took a bit of patience through 2025 to get a decent entry point. After a period of share price underperformance following the Vifor acquisition, the stock appears to be rebuilding its uptrend, and we think the setup from here is compelling. CSL's core business is collecting human plasma and processing it into life-saving therapies for rare blood disorders, immunodeficiencies, and neurological conditions. The global plasma collection network it has spent decades building is a genuine and deep moat, no competitor can replicate the scale, the donor centre footprint, or the processing infrastructure without an extraordinary amount of capital and time. The Vifor acquisition, which initially weighed on margins and the balance sheet, is increasingly looking like the right call as the iron deficiency and nephrology pipeline matures.
The H1 FY26 results showed continued earnings growth across immunoglobulins and haemophilia therapies, with network optimisation delivering cost-out benefits that are flowing through to margins. CSL pulled back alongside the broader defensive sector selloff this week, but that move feels opportunistic rather than structural. Nothing changed in the underlying business. The long-term drivers are as strong as ever: a global ageing demographic, rising rates of immune deficiency diagnoses, and ongoing expansion of plasma collection centres into Europe and China. Technically, CSL has been building a base above its 200-day moving average since April 2026, with a series of higher lows forming, the kind of accumulation pattern we like to see before a move higher. Revenue and earnings are forecast to grow at double-digit rates over the next three years. At current levels, CSL is one of the more attractive risk-reward opportunities on the ASX for investors with a 12-to-24-month horizon.
*Bottom Line: Quality Wins When the Easy Money Is Gone*
We'll wrap up with the honest assessment of where we think we are. The ASX 200 is navigating a genuinely difficult macro environment, a hawkish Fed, an RBA on hold but not easing, a stronger US dollar pressing on commodity prices, and gold breaking below key technical support for the first time in years. This is not the time to be reaching for yield in speculative miners, high-PE growth stocks with no near-term earnings, or cyclicals that need rate cuts to work. The five names we've gone through, WES, WOW, TLS, TCL, and CSL, all share the same core characteristic: they make real money from businesses that don't need the macro environment to cooperate. They have pricing power, structural moats, and long track records of rewarding shareholders through the cycle. We're not pretending these names are immune to broader market weakness, if the August RBA meeting or the July CPI print come in hawkishly, there will be another leg down in equities, and these stocks will be dragged along for part of that ride. But on a 12-month view, owning quality defensives with strong cash flows and bullish price action is where we want to be positioned while we wait for clarity. Trim the cyclicals, top up the quality, and let the dividends do the work.
*Enjoy my Research and Stock Picks?* Follow me on LinkedIn for more updates
( https://linkedin.com/in/markelzayed )
**Free Disclaimer:*
The base platform has no monthly fees, however, brokerage fees apply when buying or selling stocks through the platform.
Many thanks for reading our updates! Feel free to call us or reply to this email with suggestions. If you have some friends you think would be interested, let us know - we have a referral program available.
*Very important & unique disclaimer provided by our legal team*
This email and any files transmitted with it are confidential. If you are not the intended recipient or have received this email in error, you are not permitted to use or disclose its contents - please notify the sender immediately by return email and also delete the email and any files from your system.
Investor Pulse Research ("Investor Pulse") is a registered business name and division of Volatility Pty Ltd (ACN 669 520 174) ("Volatility") is a Corporate Authorised Representative (number 001304496) of Point Capital Pty Ltd (ABN 41 625 931 900), (AFSL No 518031).
No warranty is made as to the accuracy of the information in this message and, to the maximum extent permitted by law, Volatility disclaims all liability for any loss or damage which may be suffered by any recipient through relying on anything contained or omitted from this message. Volatility does not warrant the attached files are free from computer viruses or other defects and is provided on the basis that the user assumes all responsibility for any loss, damage or consequence resulting from use.
Any advice contained in this email is general advice and has been prepared without taking into account your financial objectives, financial situation or needs. Before acting on any advice in this email, we recommend that you consider whether it is appropriate for your circumstances. If this email contains reference to any financial products, we recommend you consider the Product Disclosure Statement (PDS) or other disclosure documents available from us, before making any decisions regarding any products.
Level 9, 255 George Street
Sydney, NSW 2000, Australia